Sisi He
State Key Laboratory Of Biotherapy And Cancer Center
Chengdu, 610041, China
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Malignant Pleural Effusion and ascites Induce Epithelial-Mesenchymal Transition and Cancer Stem-like Cell Properties via the Vascular Endothelial Growth Factor (VEGF)/Phosphatidylinositol 3-Kinase (PI3K)/Akt/Mechanistic Target of Rapamycin (mTOR) Pathway.
Journal: The Journal of biological chemistry
Published: August 11, 2016
Pseudomonas aeruginosa infection augments inflammation through miR-301b repression of c-Myb-mediated immune activation and infiltration.
Journal: Nature microbiology
Published: January 22, 2016
Extravascular red blood cells and hemoglobin promote tumor growth and therapeutic resistance as endogenous danger signals.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: November 28, 2014
Toll-like receptor 7/8 agonist, R848, exhibits antitumoral effects in a breast cancer model.
Journal: Molecular medicine reports
Published: January 23, 2014
Genetically modified human placenta‑derived mesenchymal stem cells with FGF‑2 and PDGF‑BB enhance neovascularization in a model of hindlimb ischemia.
Journal: Molecular medicine reports
Published: December 01, 2013
Dopamine receptor antagonist thioridazine inhibits tumor growth in a murine breast cancer model.
Journal: Molecular medicine reports
Published: October 24, 2013
Inhibition of FGFR signaling by PD173074 improves antitumor immunity and impairs breast cancer metastasis.
Journal: Breast cancer research and treatment
Published: October 19, 2013
Antiangiogenic therapy using sunitinib combined with rapamycin retards tumor growth but promotes metastasis.
Journal: Translational oncology
Published: July 05, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026